Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Antibe Therapeutics Inc(Pre-Merger) T.ATE

Alternate Symbol(s):  ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


TSX:ATE - Post by User

Post by Duster340on Jan 16, 2024 2:55pm
379 Views
Post# 35829709

Are we moving higher

Are we moving higherbefore the thursday info drop? maybe some last minute buying before the close tomorrow or thursday morning? funny how the stock is now just high enough for the warrants to be exercised, i am sure most of them will be converted by thursday. who drove the price higher to get above the exercise price, dan and  warrant holders of course, the same people who will be the bigest sellers when there new shares become tradeable if dan delivers us a lump of coal on thursday lol.  this whole thing feels orchastrated to me. dan new they would never get to $1.50 so they came up with the $1 warrants program and the "conversation with antibe" to generate some interest. it all worked as planned ATE get's 65m or thereabout. and shareholders may get screwed again atleast in the short term if the stock moves lower after thursday. and then the waiting game again untill the next catalyst. (now $1.01 on the bid not worth selling as there could be a jump in price ahead of thursday.)
glta
<< Previous
Bullboard Posts
Next >>